The stimulatory effect of endogenous hyperinsulinemia on breast cancer progression has been modeled through the use of a transgenic mouse model (MKR), in which a kinase-inactive form of the IGF1R is overexpressed in skeletal muscle under the muscle creatine kinase promoter (146). This evidence concerns the gene IGF1R and breast carcinoma.